
Carla J. Myers
Examiner (ID: 12282, Phone: (571)272-0747 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1807, 1655, 1643, 1634, 1644, 1609, 1654, 1682, 1621 |
| Total Applications | 2310 |
| Issued Applications | 1000 |
| Pending Applications | 334 |
| Abandoned Applications | 987 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20577567
[patent_doc_number] => 12569806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Devices, methods, and systems for capturing and sequestering atmospheric gases
[patent_app_type] => utility
[patent_app_number] => 19/244168
[patent_app_country] => US
[patent_app_date] => 2025-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 0
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19244168
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/244168 | Devices, methods, and systems for capturing and sequestering atmospheric gases | Jun 19, 2025 | Issued |
Array
(
[id] => 20277672
[patent_doc_number] => 20250302914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-02
[patent_title] => ELECTROPORATION-TARGETED DELIVERY OF RIBOSOME INACTIVATING PROTEIN GELONIN INTO MAMMALIAN CELLS
[patent_app_type] => utility
[patent_app_number] => 19/089650
[patent_app_country] => US
[patent_app_date] => 2025-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19089650
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/089650 | Electroporation-targeted delivery of ribosome inactivating protein gelonin into mammalian cells | Mar 24, 2025 | Issued |
Array
(
[id] => 19641379
[patent_doc_number] => 20240415899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS
[patent_app_type] => utility
[patent_app_number] => 18/820753
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820753
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/820753 | Bacteriotherapy for clostridium difficile colitis | Aug 29, 2024 | Issued |
Array
(
[id] => 20568736
[patent_doc_number] => 20260062657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-05
[patent_title] => METHOD AND SYSTEM FOR MITIGATING GREENHOUSE GAS EMISSIONS BY PROMOTING THE GROWTH OF METHANE-OXIDIZING BACTERIA
[patent_app_type] => utility
[patent_app_number] => 18/818581
[patent_app_country] => US
[patent_app_date] => 2024-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18818581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/818581 | METHOD AND SYSTEM FOR MITIGATING GREENHOUSE GAS EMISSIONS BY PROMOTING THE GROWTH OF METHANE-OXIDIZING BACTERIA | Aug 27, 2024 | Pending |
Array
(
[id] => 19570368
[patent_doc_number] => 20240374660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation
[patent_app_type] => utility
[patent_app_number] => 18/780491
[patent_app_country] => US
[patent_app_date] => 2024-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18780491
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/780491 | Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation | Jul 22, 2024 | Pending |
Array
(
[id] => 19860731
[patent_doc_number] => 20250099517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => Use of Lactobacillus reuteri Y7 strain for prevention or treatment of ocular diseases
[patent_app_type] => utility
[patent_app_number] => 18/774556
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774556
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774556 | Use of Lactobacillus reuteri Y7 strain for prevention or treatment of ocular diseases | Jul 15, 2024 | Pending |
Array
(
[id] => 19691275
[patent_doc_number] => 20250009820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => WOMEN'S HEALTH PROBIOTIC FORMULATIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/763204
[patent_app_country] => US
[patent_app_date] => 2024-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18763204
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/763204 | WOMEN'S HEALTH PROBIOTIC FORMULATIONS AND METHODS OF USE THEREOF | Jul 2, 2024 | Pending |
Array
(
[id] => 19657104
[patent_doc_number] => 20240424169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/757079
[patent_app_country] => US
[patent_app_date] => 2024-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757079
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/757079 | CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF | Jun 26, 2024 | Pending |
Array
(
[id] => 19432338
[patent_doc_number] => 20240300836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => COMPOSITION WITH A TIME RELEASE MATERIAL FOR REMOVING HALOGENATED HYDROCARBONS FROM CONTAMINATED ENVIRONMENTS
[patent_app_type] => utility
[patent_app_number] => 18/667427
[patent_app_country] => US
[patent_app_date] => 2024-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18667427
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/667427 | COMPOSITION WITH A TIME RELEASE MATERIAL FOR REMOVING HALOGENATED HYDROCARBONS FROM CONTAMINATED ENVIRONMENTS | May 16, 2024 | Pending |
Array
(
[id] => 19862590
[patent_doc_number] => 20250101376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => METHODS FOR FORMING THREE-DIMENSIONAL HUMAN RETINAL TISSUE IN VITRO
[patent_app_type] => utility
[patent_app_number] => 18/644764
[patent_app_country] => US
[patent_app_date] => 2024-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18644764
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/644764 | METHODS FOR FORMING THREE-DIMENSIONAL HUMAN RETINAL TISSUE IN VITRO | Apr 23, 2024 | Pending |
Array
(
[id] => 19528511
[patent_doc_number] => 20240352413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/639238
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639238 | ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF | Apr 17, 2024 | Pending |
Array
(
[id] => 20013825
[patent_doc_number] => 20250152047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-15
[patent_title] => MEDICAL DIAGNOSTIC DEVICES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/639358
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639358
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639358 | MEDICAL DIAGNOSTIC DEVICES AND METHODS | Apr 17, 2024 | Pending |
Array
(
[id] => 19528504
[patent_doc_number] => 20240352406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/639518
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639518
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639518 | Biocompatible conditioned cell medium compositions and uses thereof | Apr 17, 2024 | Issued |
Array
(
[id] => 19343593
[patent_doc_number] => 20240252556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS
[patent_app_type] => utility
[patent_app_number] => 18/631959
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/631959 | Bacteriotherapy for clostridium difficile colitis | Apr 9, 2024 | Issued |
Array
(
[id] => 19345486
[patent_doc_number] => 20240254449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => SYSTEMS AND METHODS FOR GROWTH OF INTESTINAL CELLS IN MICROFLUIDIC DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/626855
[patent_app_country] => US
[patent_app_date] => 2024-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18626855
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/626855 | Systems and methods for growth of intestinal cells in microfluidic devices | Apr 3, 2024 | Issued |
Array
(
[id] => 19433857
[patent_doc_number] => 20240302355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => METHOD AND SYSTEM FOR DETERMINING INTEGRATED METABOLIC BASELINE AND POTENTIAL OF LIVING CELLS
[patent_app_type] => utility
[patent_app_number] => 18/609912
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609912
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/609912 | METHOD AND SYSTEM FOR DETERMINING INTEGRATED METABOLIC BASELINE AND POTENTIAL OF LIVING CELLS | Mar 18, 2024 | Pending |
Array
(
[id] => 19418378
[patent_doc_number] => 20240294501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => ISLET CELL MANUFACTURING COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/581700
[patent_app_country] => US
[patent_app_date] => 2024-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581700
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581700 | Islet cell manufacturing compositions and methods of use | Feb 19, 2024 | Issued |
Array
(
[id] => 19447236
[patent_doc_number] => 20240307366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/581245
[patent_app_country] => US
[patent_app_date] => 2024-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581245
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/581245 | Use of HSP70 as a regulator of enzymatic activity | Feb 18, 2024 | Issued |
Array
(
[id] => 19431011
[patent_doc_number] => 20240299509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/437633
[patent_app_country] => US
[patent_app_date] => 2024-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18437633
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/437633 | NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS | Feb 8, 2024 | Pending |
Array
(
[id] => 19110460
[patent_doc_number] => 20240122210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/394679
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394679 | MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION | Dec 21, 2023 | Pending |